Clinical Trial Update: Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating glutamine therapy for hemolysis-associated pulmonary hypertension in patients with sickle cell disease. Study completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Sickle Cell Disease

Drugs mentioned

• glutamine therapy (glutamine)

Snippet

Sponsor: UCSF Benioff Children's Hospital Oakland | Conditions: Pulmonary Hypertension, Sickle Cell Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-06-10